 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Soy Isoflavones and Breast Cancer Risk Reduction
|
|
|
|
Phase II
|
|
|
|
03-260
UTMB GCRC #635, NIH R01-CA95545, NIH NCRR GCRC M01 RR00073, NCT00204490
|
|
| |
Phase II Trial - Breast Cancer Chemoprevention by Lovastatin
|
|
|
|
Phase II
|
|
|
|
BRSNSTU0010
NCT00285857
|
|
| |
Simvastatin in Preventing a New Breast Cancer in Women Who Are at High Risk for a New Breast Cancer After Undergoing Surgery for Ductal Carcinoma in Situ or Stage I, Stage II, or Stage III Breast Cancer
|
|
|
|
Phase II
|
|
|
|
JHOC-J0485
JHOC-SKCCC-J0485, JHOC-04100404, NCT00334542
|
|
| |
Simvastatin and Anastrozole in Treating Postmenopausal Women With Invasive Breast Cancer, Ductal Carcinoma In Situ, or a High Risk of Breast Cancer
|
|
|
|
Phase II
|
|
|
|
JHOC-J05100
JHOC-SKCCC-J05100, NCT00354640
|
|
| |
Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
|
|
|
|
Phase II
|
|
|
|
102/07
NCT00496288
|
|
| |
Study of Breast Cancer Prevention by Letrozole in High Risk Women
|
|
|
|
Phase II
|
|
|
|
10587
NCT00579826
|
|
| |
IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
|
|
|
|
Phase I
|
|
|
|
CHNMC-IRB-03178
NCT00100893
|
|
| |
Green Tea Extract in Treating Women With Hormone Receptor-Negative Stage I, Stage II, or Stage III Breast Cancer
|
|
|
|
Phase I
|
|
|
|
MDA-MDA04-4-01
MDA04-4-01, NCT00516243, MDA-2006-0521, CPMC-IRB-AAAB7638
|
|
| |
Atorvastatin in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
|
|
|
|
Phase I
|
|
|
|
MDA-MDA05-6-01
MDA05-6-01, MDA-2006-0185, NCT00637481
|
|
| |
White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors
|
|
|
|
Phase I
|
|
|
|
CHNMC-07213
07213, NCT00709020
|
|
